By The Registry Staff Seattle-based Bonum Therapeutics, a rising star in the biotechnology sector, is set to double its current footprint in August as it plans to relocate to a larger office space in Seattle's Eastlake neighborhood. The company, which specializes in the development of targeted protein drugs for cancer treatment, is moving to a […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle's most storied piece of Westlake Avenue real estate is headed toward...
ByThe RegistrySeptember 25, 2026Construction has begun on replacement stations in Monroe and Lake Stevens roughly...
ByThe RegistrySeptember 25, 2026A San Francisco-born fast casual chicken concept is following a proven multi-unit...
ByThe RegistrySeptember 25, 2026Wells Fargo's September economic outlook points to a widening split in Pacific...
ByThe RegistrySeptember 25, 2026